Answers are grounded in this paper and cite their sources.
antibacterial properties compared with azithromycin. Also, CSY5669 was immunomodulatory at concentrations well below 1% of the minimum inhibitory concentration, which would minimize selection for macrolide-resistant bacteria if it were to be used as a host-directed therapy. This study highlights the potential of CSY5669 as a possible adjunctive therapy in pneumonia caused by MRSA, as CSY5669 could enhance bacterial eradication while simultaneously limiting inflammation-associated pathology.
No takes yet. Share an insight, caveat, or question.
Saris et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: